First-Line Type 2 Diabetes Treatments Evolving

Dr. Rita Kalyani explains metformin's role and the rising prominence of GLP-1 and SGLT2 agents for cardiovascular and kidney benefit.

Play episode from 12:49

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!